Stereotaxic treatment in extrapyramidal diseases
Arseni, C.; Iacob, M.; Simionescu, M.
Neurologia Psihiatria Neurochirurgia 18(6): 525-538
1973
ISSN/ISBN: 0028-386X PMID: 4597684 Document Number: 68467
Document emailed within 1 workday
Related Documents
Brice, A. 1998: Genetics of extrapyramidal diseases Revue Neurologique (Paris) 154(11): 739-742Carrieri, P. 1977: GABA and diseases of the extrapyramidal system Acta Neurologica 32(5): 697-704
Tkachev, R.A.; Markova, E.D.; Gotovtseva, E.V.; Barkhatova, V.P.; Ivanova-Smolenskaia, I.A. 1973: Principles of the pathogenetic therapy of congenital extrapyramidal diseases Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(4): 513-519
Barkhatova, V.P.; Kandel', E.I.; Demina, E.G. 1981: Approaches to the study of dopamine metabolism in various extrapyramidal diseases Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 81(7): 1021-1029
Shustin, V.A.; Korzenev, A.V.; Gorskiĭ, G.D.; Vovin, R.I. 1991: Stereotaxic cingulotomy in the complex treatment of a schizophrenic patient with obsessive-compulsive disorder, resistant to treatment Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(5): 92-95
Derome, P.J.; Jedynak, C.P.; Visot, A.; Delalande, O. 1989: Stereotaxic treatment in Parkinson's disease La Revue du Praticien 39(8): 670-674
Iatsuk, S.L.; Stepanova, T.S.; Bersnev, V.P. 1997: Stereotaxic amygdalotomy in the treatment of children with epilepsy Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 3: 27-29
Nesterov, L.N.; Balakleets, R.M.; Skupchenko, V.V.; Chernyshov, S.N. 1990: Extrapyramidal dyskinesias and their neurosurgical treatment Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 1: 13-15
Wester, K.; Hauglie-Hanssen, E. 1984: CT-guided stereotaxic diagnosis and treatment intracranial tumors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 104(32): 2255-2257
Siegfried, J. 1988: The current place of stereotaxic neurosurgery in the treatment of involuntary movements Therapeutische Umschau. Revue Therapeutique 45(1): 50-55
Ivanović, M.; Bosić, D.; Vucković, S. 1974: Occurrence of extrapyramidal-pyramidal syndrome during treatment with psychopharmaceutics Neuropsihijatrija 22(1-4): 139-141
Bidziński, J.; Krzymiński, T.; Ostrowski, K. 1979: Stereotaxic ventroposteromedial thalamotomy in the treatment. Clinical observations and physiopathological considerations Neurologia i Neurochirurgia Polska 13(4): 417-422
Fadrus, P.; Máca, K.; Smrcka, V.; Nádvorník, P. 1998: Minimally invasive treatment of traumatic cerebral hematoma. Further experience with stereotaxic evacuation Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 77(10): 441-444
Nádvorník, P.; Pogády, P. 1987: Stereotaxic surgical treatment of hypertensive cerebral hemorrhage guided by computer tomography Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 66(7): 534-539
Bukowczyk, A.; Wasik, A.; Horodnicki, J. 1974: Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs Psychiatria Polska 8(2): 143-148
Chkhenkeli, S.A. 1982: Neurophysiologic basis and results of stereotaxic combined surgical treatment of complex forms of epileptic seizures Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 82(6): 91-101
Fonzari, M.; Fontanini, F.; Monzeglio, R.M.; Piola, P.; Santiccioli, L. 1991: Protirelin tartrate. Evaluation of its effects on pyramidal-extrapyramidal rigidity in the aged during protracted treatment La Clinica Terapeutica 138(5-6): 227-232
Babić, K.; Borcić, D.; Beus, A. 1977: Extrapyramidal syndrome as a side-effect of treatment with thiethylperazine (torecan) and metoclopramide (Reglan) a review of ten cases Lijecnicki Vjesnik 99(3): 181-184
Inada, T. 1996: Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients Nihon Shinkei Seishin Yakurigaku Zasshi 16(5): 181-185
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347